The persistent upward trajectory of healthcare costs in the United States continues to exert immense pressure on both employers and employees, leading to a critical shift in how workers access and manage their health. A recent analysis from ADP, published on April 14, 2026, highlights a concerning trend: employees are increasingly delaying necessary medical care due to financial concerns, a decision that, while seemingly offering short-term relief, is projected to incur significantly higher costs for employers in the long run. This dynamic underscores a deepening crisis within the employer-sponsored health benefits landscape, where the pursuit of cost containment by companies often inadvertently creates greater burdens and health risks for their workforce.
The Unrelenting Ascent of Healthcare Expenses: A Historical Context
The phenomenon of ballooning healthcare costs is far from a novel revelation for benefits leaders. For years, experts have meticulously tracked the relentless escalation, identifying a complex interplay of factors contributing to this financial juggernaut. Historically, the U.S. healthcare system, largely tied to employer-sponsored insurance since the mid-20th century, has seen costs outpace general inflation for decades. This trend intensified significantly in the late 20th and early 21st centuries, driven by technological advancements, an aging population, and the proliferation of chronic diseases.
Key drivers of this upward trajectory include the soaring prices of pharmaceutical drugs, particularly specialty medications and innovative treatments. The U.S. operates under a unique system where drug manufacturers largely set their own prices, often without the same level of negotiation seen in other developed nations. This, coupled with the increasing utilization of healthcare services—partially a consequence of an aging demographic and improved diagnostic capabilities—creates a continuous demand-side pressure on costs.
Moreover, the healthcare industry has witnessed significant consolidation among providers, with hospitals and physician groups merging into larger systems. While proponents argue this can lead to efficiencies, evidence often suggests it reduces competition, allowing consolidated entities to command higher prices for their services. Inflation across the broader economy also feeds into healthcare costs, affecting everything from medical supplies to facility maintenance. Critically, a growing shortage of skilled healthcare professionals, including nurses, doctors, and specialized technicians, further exacerbates the problem by driving up labor costs, which are then passed on to insurers and, ultimately, employers and employees.
Benefits consultant Mercer, for instance, reported last summer that health benefit cost increases were projected to hit a 15-year high, a stark indicator of the unsustainable path the system is on. Many employers, grappling with these escalating expenses, have resorted to various strategies, a significant portion of which involves shifting a greater share of the financial burden onto their employees. This often translates into higher deductibles, increased co-payments, and more substantial employee contributions to premiums.
Supporting these findings, the Business Group on Health similarly reported last summer that 12% of employers had already increased overall employee contributions, while 9% had raised employees’ out-of-pocket costs. More tellingly, a significant majority of surveyed employers indicated they were actively considering taking similar actions to mitigate the impact of rising costs on their own balance sheets. This approach, while offering immediate financial relief to employers, sets the stage for the adverse outcomes now being observed among the workforce.
The Employee Response: A Growing Crisis of Access and Confidence
The consequences of these cost-shifting strategies are now vividly apparent in employee behavior. ADP’s latest findings paint a concerning picture: employees are increasingly making difficult choices about their healthcare. The most direct impact is the delay or complete deferral of medical care. This isn’t limited to elective procedures; often, it includes crucial preventative screenings, necessary follow-up appointments for chronic conditions, and even acute care for less severe ailments, all due to concerns about affordability.
This reluctance to seek professional medical help leads many to alternative, often less reliable, sources. According to ADP, a staggering 68% of workers are turning to the internet for medical advice, attempting to self-diagnose or find home remedies. Even more strikingly, 27% are now consulting generative AI for health-related guidance. While the internet and AI can offer quick information and preliminary insights, they lack the nuanced diagnostic capabilities and personalized understanding of a trained medical professional. This reliance on unverified or generalized digital advice carries inherent risks, including potential misdiagnosis, delayed treatment for serious conditions, and the spread of misinformation, which can ultimately lead to worse health outcomes and more complex, expensive interventions down the line.
The "ugly side" of the focus on wellness initiatives also emerges from these findings. While ADP noted a positive trend in workers prioritizing wellness activities such as mindfulness, food choices, and exercise, this shift is often driven by a defensive posture against high healthcare costs rather than a purely proactive approach to holistic health. Employees are trying to stay healthy to avoid needing expensive medical care, rather than leveraging comprehensive wellness programs that ideally should be integrated with accessible, affordable clinical services.
Furthermore, the financial strain on employees is palpable. While workers, on average, have managed to save slightly more for healthcare expenses compared to previous years, this aggregate masks a disturbing underlying trend: the number of individuals with less than $500 saved for medical costs has actually increased. This indicates a growing bifurcation, where some manage to save, but a significant portion of the workforce remains highly vulnerable. The percentage of employees who do not feel prepared to handle out-of-pocket expenses has jumped dramatically from 31% in 2020 to 39% in 2025, signaling a deepening sense of financial insecurity and stress among the working population regarding their health. This medical debt crisis contributes to overall financial precarity, impacting credit scores, housing stability, and mental well-being, creating a ripple effect across their lives.
These findings are not isolated. The Employee Benefit Research Institute (EBRI) corroborated ADP’s observations last month, also reporting that a substantial number of workers are delaying care. This consistent data from multiple reputable sources paints a clear and alarming picture of a workforce increasingly constrained by healthcare costs, compelled to make compromises that could jeopardize their long-term health.
Employer Dilemma: Short-Term Savings vs. Long-Term Costs
For employers, the dilemma is acute. The immediate pressure to contain rising benefits costs often leads to the implementation of strategies that, while providing short-term budgetary relief, can paradoxically inflate expenses in the long run. The decision to shift more costs onto employees through higher deductibles, increased co-pays, and greater premium contributions, as reported by Mercer and the Business Group on Health, is a prime example of this trade-off.
The core issue lies in the counterintuitive nature of delayed care. While employees might avoid a $200 co-pay for a doctor’s visit or a $500 diagnostic test today, postponing such care often allows underlying conditions to worsen, leading to more complex, invasive, and exponentially more expensive treatments in the future. A simple, affordable screening for early-stage cancer, if delayed, could result in advanced-stage treatment costing hundreds of thousands of dollars. Untreated hypertension can escalate into heart disease, strokes, or kidney failure, all requiring extensive and costly medical interventions.
Deloitte’s healthcare practice principal articulated this critical point last September, emphasizing that employers could significantly mitigate the cost of complex conditions like cancer by actively covering and even facilitating screenings. Making these preventative services easily accessible, potentially even on-site, can lead to early detection, more effective treatments, and substantial savings compared to managing advanced diseases. This proactive approach, though requiring upfront investment, is framed as a strategic necessity for sustainable workforce health and financial stability.
Beyond direct medical costs, delayed care has broader implications for employer productivity. A workforce that is sicker, more stressed about healthcare expenses, and less likely to seek timely treatment will inevitably experience higher rates of absenteeism and presenteeism (being at work but not fully productive due to health concerns). This impacts overall business output, innovation, and employee morale, potentially leading to increased turnover as employees seek companies with more robust and affordable health benefits.
The Role of Emerging Technologies and Pharmaceuticals: The GLP-1s Case Study
The landscape of healthcare costs is further complicated by the emergence of new technologies and pharmaceutical innovations. The rise of glucagon-like peptide-1 (GLP-1) receptor agonists, medications primarily used for diabetes and increasingly for obesity management, presents a compelling case study for employers. These drugs, while highly effective, come with a substantial price tag, posing a significant challenge for benefits plan design.
However, a major analysis conducted by Aon offers a nuanced perspective. Their research indicates that sustained GLP-1 use, despite its high upfront cost, may actually lead to a decrease in overall healthcare expenses for employers over time. This is attributed to the drugs’ effectiveness in managing diabetes and obesity, conditions that are major drivers of healthcare costs due to associated complications like cardiovascular disease, kidney failure, and joint problems. By effectively controlling these primary conditions, GLP-1s can prevent or mitigate the need for more expensive interventions, hospitalizations, and long-term care associated with their progression. This applies to both workers with diagnosed diabetes and those struggling with obesity, highlighting the potential for these medications to be a cost-saving measure in the long run, despite their initial expense. This complex equation forces employers to weigh immediate budget concerns against the potential for significant future savings and improved employee health outcomes.
Broader Implications for Workforce Health and Productivity
The current trajectory of healthcare costs and employee responses carries profound implications beyond individual health outcomes and company balance sheets. On a macroeconomic level, a less healthy workforce is a less productive workforce. This can dampen economic growth, strain public health infrastructure, and exacerbate existing health disparities, particularly impacting lower-income workers who are often least able to absorb rising out-of-pocket costs.
For businesses, the ability to attract and retain top talent is increasingly tied to the quality and affordability of health benefits. Companies perceived as offering inadequate or overly expensive healthcare coverage may struggle to compete in a tight labor market, leading to higher recruitment costs and a less experienced workforce. Employee stress related to healthcare costs also takes a toll on mental health, further impacting productivity, engagement, and overall well-being. This creates a vicious cycle where financial stress leads to health issues, which in turn leads to more financial stress.
The reliance on the internet and AI for medical advice, while a symptom of inaccessible care, also presents a double-edged sword. While it can empower individuals with information, it also places a greater burden on individuals to discern accurate, personalized advice, a task for which many are ill-equipped. This highlights a gap in reliable, accessible, and affordable primary care that technology alone cannot fully bridge.
Looking Ahead: Strategies for Mitigation and Sustainable Solutions
Addressing this multifaceted crisis requires a concerted effort from all stakeholders: employers, employees, healthcare providers, and policymakers.
For employers, a paradigm shift from pure cost-shifting to strategic investment in employee health is crucial. This involves:
- Re-evaluating Benefit Designs: Moving beyond high-deductible plans that disproportionately burden employees, exploring options like lower deductibles for preventative care, or incorporating value-based care models.
- Increasing Transparency: Providing employees with clear, accessible information about healthcare costs and quality for different providers and treatments, empowering them to make informed decisions.
- Expanding Access to Virtual Care: Telehealth and virtual primary care can reduce barriers to access, especially for routine consultations and mental health support, often at a lower cost.
- Investing in Proactive and Preventative Care: Following Deloitte’s advice, covering and promoting screenings, chronic disease management programs, and robust wellness initiatives that are truly integrated with affordable clinical care.
- Exploring Direct Contracting: Bypassing traditional insurers to negotiate directly with healthcare providers for services, potentially achieving better rates and more tailored care.
- Considering Specialized Programs: For high-cost conditions like diabetes and obesity, carefully evaluating the long-term cost-effectiveness of covering innovative treatments like GLP-1s.
Policymakers also have a critical role to play in fostering a more equitable and affordable healthcare system:
- Addressing Market Failures: Implementing regulations to curb provider consolidation, promote price transparency across the entire healthcare supply chain, and enhance competition.
- Drug Price Negotiation: Empowering government entities to negotiate pharmaceutical prices, similar to practices in other developed nations.
- Promoting Value-Based Care: Shifting away from fee-for-service models towards payment systems that reward quality outcomes and cost-efficiency.
- Strengthening Public Health Infrastructure: Investing in community-based health initiatives and expanding access to primary care, particularly in underserved areas.
For employees, understanding their benefits, engaging in financial literacy around healthcare costs, and advocating for more comprehensive and affordable coverage through their workplaces and broader political processes are essential.
Ultimately, the current trajectory where employees delay care due to cost is unsustainable. It jeopardizes individual health, strains employer resources in the long run, and undermines national productivity. A collaborative, strategic approach focused on prevention, transparency, and accessible, affordable care is not merely an ethical imperative but an economic necessity for a healthy, resilient workforce and a thriving economy. The insights from ADP and other research serve as a critical call to action for all stakeholders to re-evaluate current practices and forge a path toward a more sustainable and equitable healthcare future.
